New data suggest that incidence and prevalence of inflammatory bowel diseases [IBD] are
still increasing worldwide, and approximately 0.2% of the European population suffer from …

OBJECTIVES: The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE)
program was initiated by the International Organization for the Study of Inflammatory Bowel …

Background & Aims A comprehensive knowledge of the natural history of ulcerative colitis
(UC) helps understand disease evolution, identify poor prognostic markers and impact of …

Background & Aims We evaluated the efficacy and safety of upadacitinib, an oral selective
inhibitor of Janus kinase 1, as induction therapy for ulcerative colitis (UC). Methods We …

Background There has been burgeoning interest in quality of life (QoL) in inflammatory
bowel disease (IBD) in recent decades, with hundreds of studies each year now assessing …

As a chronic inflammatory disease, ulcerative colitis has significant negative impact on the
quality of life (QoL) of patients. Since the disease affects many aspects of QoL, comprising …

AIM: To investigate patient-reported outcomes from, and adherence to, a low FODMAP diet
among patients suffering from irritable bowel syndrome and inflammatory bowel disease …

The role of liver biopsy in the diagnosis of hepatocellular carcinoma (HCC) has been
challenged over time by the ability of imaging techniques to characterize liver lesions in …

Background & Aims Although perceived stress (PS) has been associated with symptomatic
flares in inflammatory bowel disease, clinical and physiological measures associated with …

Background To individualize treatment with mesalazine for ulcerative colitis relapses
through a self-managed, web-based solution to optimize the short-term disease course …